#Alaska Native

The program supports American Indian/Alaska Native people, who experience the highest rates of hepatitis C virus infection.

A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.

Here’s how the funding will reach American Indians and Alaska Natives, who see higher rates of HIV, hepatitis C and STIs.

Sofosbuvir-based regimens were well tolerated and cure rates were high in this population.

Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.

But American Indians and Alaska Natives saw the sharpest increase in deaths involving methamphetamines. Here’s a possible solution.

Such a collaboration successfully provided treatment to a population of Native Americans and Alaska Natives.

Recent hepatitis C data shows the American Indian and Alaska Native population had the highest rate of new infections of all ethnic groups.